Atlas Trials

Pasireotide Treatment for Neuroendocrine Tumor

Clinical trial NCT02779257 · WITHDRAWN

Trial details

NCT number
NCT02779257
Sponsor
University of Maryland, Baltimore
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Gastro-enteropancreatic Neuroendocrine Tumor
Start date
2016-04-01
Primary completion
2016-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.